APT Medical Inc. (688617.SS)
CNY 359.11
(-1.08%)
CNY 359.11
(-1.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.63 Billion | 1.21 Billion | 828.68 Million | 479.43 Million | 403.96 Million | 241.77 Million |
| Cost of Revenue | 515.34 Million | 350.16 Million | 252.84 Million | 142.12 Million | 117.89 Million | 75.48 Million |
| Gross Profit | 1.11 Billion | 865.85 Million | 575.84 Million | 337.3 Million | 286.07 Million | 166.28 Million |
| Operating Expenses | 563.65 Million | 477.1 Million | 375.19 Million | 214.26 Million | 190.13 Million | 143.64 Million |
| Selling, General and Administrative Expenses | 364.15 Million | 307.57 Million | 215.56 Million | 126.13 Million | 100.23 Million | 78.54 Million |
| Research and Development Expenses | 237.91 Million | 174.87 Million | 134.87 Million | 71.89 Million | 70.42 Million | 53.37 Million |
| Other Expenses | -61.03 Million | -5.34 Million | 24.75 Million | 16.23 Million | 19.47 Million | -389.38 Thousand |
| Cost and Expenses | 1.04 Billion | 827.27 Million | 628.03 Million | 356.39 Million | 308.02 Million | 219.12 Million |
| Operating Income | 600.41 Million | 396.98 Million | 222.5 Million | 119.44 Million | 92.09 Million | 23.6 Million |
| Interest Expense | 3.68 Million | 1.45 Million | 1.62 Million | 830.97 Thousand | 257.57 Thousand | 268.26 Thousand |
| Income Tax Expense | 74.23 Million | 54.97 Million | 26.7 Million | 17.01 Million | 13.27 Million | 6.53 Million |
| Earnings before Tax | 596.36 Million | 395.13 Million | 221.55 Million | 121.21 Million | 91.35 Million | 23.21 Million |
| Net Income | 533.92 Million | 358.01 Million | 207.92 Million | 110.77 Million | 82.57 Million | 21.51 Million |
| Earnings Per Share Basic | 5.54 | 5.37 | 3.12 | 1.66 | 1.24 | 0.43 |
| Earnings Per Share Diluted | 5.46 | 5.37 | 3.12 | 1.66 | 1.24 | 0.43 |
| Weighted Average Shares Outstanding | 96.29 Million | 66.67 Million | 66.67 Million | 66.67 Million | 66.67 Million | 50.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 97.75 Million | 66.67 Million | 66.67 Million | 66.67 Million | 66.67 Million | 50.02 Million |
| Gross Margin | 0.68 | 0.71 | 0.69 | 0.70 | 0.71 | 0.69 |
| EBIT Margin | 0.41 | 0.38 | 0.30 | 0.30 | 0.27 | 0.13 |
| Profit Margin | 0.33 | 0.29 | 0.25 | 0.23 | 0.20 | 0.09 |
| EBITDA | 672.4 Million | 453.02 Million | 256.2 Million | 143.21 Million | 106.29 Million | 35.47 Million |
| Earnings Before Tax Margin | 0.37 | 0.33 | 0.27 | 0.25 | 0.23 | 0.10 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 523.86 Million | 539.16 Million | 449.49 Million | 431.95 Million | 1.63 Billion | 425.72 Million |
| Cost of Revenue | 143.63 Million | 157.62 Million | 127.42 Million | 138.64 Million | 515.34 Million | 124.65 Million |
| Gross Profit | 380.23 Million | 381.54 Million | 322.06 Million | 293.31 Million | 1.11 Billion | 301.07 Million |
| Operating Expenses | 183.94 Million | 170.22 Million | 177.67 Million | 165.14 Million | 594.79 Million | 155.54 Million |
| Selling, General and Administrative Expenses | 252.27 Million | 105.31 Million | 112.15 Million | 84.75 Million | - | 131.08 Million |
| Research and Development Expenses | 68.96 Million | 62.9 Million | 65.61 Million | 64.29 Million | - | 59.38 Million |
| Other Expenses | -137.29 Million | -2 Million | 90.08 Thousand | -16.1 Million | -11.54 Million | 146.18 Thousand |
| Cost and Expenses | 327.57 Million | 327.84 Million | 305.1 Million | 303.78 Million | 1.11 Billion | 280.19 Million |
| Operating Income | 199.52 Million | 211.31 Million | 144.39 Million | 128.16 Million | 519.9 Million | 162.8 Million |
| Interest Expense | 489.86 Thousand | 370.42 Thousand | 713.2 Thousand | 605.5 Thousand | 3.68 Million | 858.66 Thousand |
| Income Tax Expense | 14.5 Million | 30.39 Million | 19.82 Million | 16.65 Million | 74.23 Million | 19.02 Million |
| Earnings before Tax | 198.49 Million | 228.58 Million | 155.38 Million | 143.01 Million | 600.49 Million | 162.94 Million |
| Net Income | 185.58 Million | 202.41 Million | 140.14 Million | 130.67 Million | 533.92 Million | 145.85 Million |
| Earnings Per Share Basic | 1.91 | 2.09 | 2.10 | 1.95 | - | 2.18 |
| Earnings Per Share Diluted | 1.91 | 2.09 | 2.07 | 1.97 | - | 2.15 |
| Weighted Average Shares Outstanding | 97.32 Million | 96.94 Million | 66.86 Million | 66.86 Million | 66.86 Million | 66.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 97.32 Million | 96.94 Million | 67.7 Million | 66.33 Million | 67.41 Million | 67.83 Million |
| Gross Margin | 0.73 | 0.71 | 0.72 | 0.68 | 0.68 | 0.71 |
| EBIT Margin | 0.38 | 0.43 | 0.35 | 0.34 | - | 0.35 |
| Profit Margin | 0.35 | 0.38 | 0.31 | 0.30 | 0.33 | 0.34 |
| EBITDA | 198.98 Million | 232.24 Million | 157.45 Million | 146.75 Million | - | 147.78 Million |
| Earnings Before Tax Margin | 0.38 | 0.39 | 0.32 | 0.30 | 0.32 | 0.38 |
ALHUN
PENINLAND
EXROF
HBOR3
3166
KANDAGIRI